Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Thomas Henry Glocer
Age : 60
Public asset : 8,858,422 USD
Linked companies : Merck & Co., Inc. - Morgan Stanley - Publicis Groupe S.A.
Summary 
Thomas Henry Glocer is an American entrepreneur and businessperson who founded Angelic Ventures LP, BlueVoyant LLC and Communitas Capital Partners LLC and who has been at the helm of 6 different companies. Currently, Mr. Glocer holds the position of Executive Chairman at BlueVoyant LLC, Chief Executive Officer at Blueteam Investor LLC and Partner at Communitas Capital Partners LLC.

He is also Member-Presidents Council International Activities at Yale University, Member-Madison Council at The Library of Congress (District of Columbia), Member of Supreme Court of the United States, Member of New York State Bar Association, Member of The American Law Institute, Member of The Business Council, Member of European Business Leaders' Convention and Managing Partner at Angelic Ventures LP and on the board of 12 other companies.

In his past career Mr. Glocer held the position of Chief Executive Officer at Capitolis, Inc., Chief Executive Officer & Director at Reuters Group Plc, Chief Executive Officer at Thomson Reuters Plc, Chief Executive Officer & Director at Thomson Reuters Corp., Vice President & Deputy Counsel at Reuters America Holdings, Inc., Director at Council on Foreign Relations, Inc. and Member-International Business Council at Forum Mondial de L'Economie.

Mr. Glocer received an undergraduate degree from The Trustees of Columbia University in The City of New York and a graduate degree from Yale University.


Current positions of Thomas Henry Glocer 
NameTitle Since
Merck & Co., Inc.
(Pharmaceuticals)
Independent Director 2007
Morgan Stanley
(Investment Banking & Brokerage Services)
Lead Independent Director 2017
Publicis Groupe S.A.
(Advertising & Marketing)
Member-Supervisory Board 2015
Blueteam Investor LLC Chief Executive Officer -
BlueVoyant LLC Executive Chairman 2017
The International Business Council Director 2011
The Atlantic Council of the United States Director -
The Cleveland Clinic Foundation Trustee -
Merck Sharp & Dohme Corp. Director 2009
K2 Intelligence LLC Director -
K2 Intelligence, Inc. Director 2012
Verto Analytics, Inc. Director -
Verto Analytics Oy Director -
Reynen Court LLC Non-Executive Director -
Yale University Member-Presidents Council International Activities 2011
The Library of Congress (District of Columbia) Member-Madison Council -
Supreme Court of the United States Member 2010
New York State Bar Association Member 1984
The American Law Institute Member 2011
The Business Council Member -
European Business Leaders' Convention Member 2013
Angelic Ventures LP Managing Partner 2012
Communitas Capital Partners LLC Co-Founder, Partner 2017


Holdings of Thomas Henry Glocer 
NameEquities%Valuation
Morgan Stanley (MS)
(Investment Banking & Brokerage Services)
92,2870.0050%8,461,795 USD
Merck & Co., Inc. (MRK)
(Pharmaceuticals)
5,1000.0002%396,627 USD


Thomas Henry Glocer: Personal Network 
Most Read News 
08/02JACK DORSEY : Twitter's Dorsey leads $29 billion buyout of lending pioneer Afterpay
RE
08/03CARLOS TAVARES : Stellantis lifts margin goal as Tavares' turnaround kicks in
RE
07/28MARK ZUCKERBERG : Facebook's slowdown warning hangs over strong ad sales, while Zuckerberg talks 'metaverse'
RE
07/20JEFF BEZOS : billionaire Bezos has successful suborbital jaunt
RE
08/02MICHAEL EVANS : London Shares Rise as China Regulatory Concerns Ease
DJ
07/26JEFF BEZOS : Bezos-backed plant food firm NotCo joins unicorn club after latest funding
RE
07/26MICHAEL KLEIN : EV maker Lucid rises in Nasdaq debut after merger with Klein-backed SPAC
RE
07/27RAJESH KUMAR : GE warns of inflationary pressure after lifting cash flow estimate
RE
07/26JEFF BEZOS : Bezos offers NASA $2 billion in exchange for moon mission contract
RE
07/27IAN READ : Exclusive-Rivian ready to invest $5 billion in second U.S. assembly plant -document
RE
More news


© 2021 People and Ownership :   
Thomas Henry Glocer : Connections